
Initiative for Molecular Profiling and Advanced Cancer Therapy (IMPACT): An MD Anderson Precision Medicine Study
Author(s) -
Apostolia M. Tsimberidou,
David S. Hong,
Yong Yang,
Carrie Cartwright,
Jennifer J. Wheler,
Gerald S. Falchook,
Aung Naing,
Siqing Fu,
Sarina A. Piha-Paul,
Filip Janků,
Funda MericBernstam,
Patrick Hwu,
Bryan K. Kee,
Merrill S. Kies,
Russell R. Broaddus,
John Mendelsohn,
Kenneth R. Hess,
Razelle Kurzrock
Publication year - 2017
Publication title -
jco precision oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.405
H-Index - 22
ISSN - 2473-4284
DOI - 10.1200/po.17.00002
Subject(s) - profiling (computer programming) , precision medicine , medicine , cancer medicine , cancer therapy , oncology , cancer , computer science , pathology , operating system
Genomic profiling is increasingly used in the management of cancer. We have previously reported preliminary results of our precision medicine program. Here, we present response and survival outcomes for 637 additional patients who were referred for phase I trials and were treated with matched targeted therapy (MTT) when available.